NEUCHATEL, Switzerland-Monday 29 November 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) today announced the findings of a study published in Clinical Medicine Insights: Pediatrics in which Dr. Harish Kumar and colleagues at IPE Global in New Delhi, India reported on their experience using the Masimo Rad-G® Pulse Oximeter to aid health providers in pneumonia case detection and management in more than 4,500 children under five years who presented with symptoms of acute respiratory infection (ARI). Rad-G is a rugged, portable, handheld Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximeter and noninvasive respiration rate monitor from the pleth (RRp®). The researchers found that Rad-G was “highly acceptable among health workers” and aided the “timely classification and treatment” of pneumonia—helping them achieve correct case management in more than 91% of cases of ARI and reduce the unnecessary use of ... Read more »

• Colin Bond to retire as Chief Financial Officer of Vifor Pharma Group

• Succession recruitment ongoing

ST. GALLEN, Switzerland-Tuesday 30 November 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- Regulatory News:

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR

Vifor Pharma Group today announced that Colin Bond, Chief Financial Officer will retire from the company by the end of December 2021 at his own request. Vifor Pharma is currently in the recruiting process for the new Chief Financial Officer, to be announced once the successor has been identified.

Abbas Hussain, Chief Executive Officer of Vifor Pharma, commented: "On behalf of the company I would like to thank Colin for his valuable contributions and leadership during his tenure at Vifor Pharma. For his next phase of his life I wish him all the best and satisfaction in his futur ... Read more »

 ALASTIN Skincare® was the fastest growing brand in the U.S. professional skincare market in 20201

 ALASTIN’s patented, differentiated technology and products are highly synergistic with Galderma’s premium portfolio

 Galderma will support further product innovation and geographical expansion of ALASTIN’s portfolio

ZUG, Switzerland & CARLSBAD, Calif-Monday 29 November 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- Galderma, the world’s largest independent dermatology company, announced that it has signed a definitive agreement to acquire ALASTIN Skincare®, Inc. (“ALASTIN”), a specialty aesthetics company dedicated to developing innovative and clinically-tested physician-dispensed skincare products. The acquisition is subject to customary closing conditions and necessary regulatory approvals. Financial terms of the transaction have not been disclosed.

ALASTIN’s premium ... Read more »